Search ResultsElectronic Resources 
by
Banna, Fathia Jehad, author.
Format:
Excerpt:
immunosuppressive therapy following liver, heart and kidney transplantation, because of its better survival results
by
Russell, Tara Anastasia, author.
Format:
Excerpt:
, evaluations of Share 35 have been limited to traditional markers of quality in transplantation, namely pre
by
Cassady, Kaniel Marvin, author.
Format:
Excerpt:
hematopoietic cell transplantation (HCT) is a curative immunotherapy for hematological malignancies. However
by
Leung, Steven Tsz King, author.
Format:
Excerpt:
Currently, the only treatment option for end-stage pulmonary disease in CF is lung transplantation
by
Khan, Md. Ehsan, author.
Format:
Excerpt:
There is ever increasing disparity between number of organs needed for transplantation and numbers
by
Winston-Mcpherson, Gabrielle Noel, author.
Format:
Excerpt:
response during organ transplantation, inflammation disorders, and certain types of cancer. Malassezin is a
by
Diamandopoulos, Athanasios Antoniou, author.
Format:
Excerpt:
-Tx). The influence of the el'll on the outcome of renal transplantation (Tx) was also assessed. The
by
Penton, Christopher M., author.
Format:
Excerpt:
autologous SP cell transplantation as dystrophic SP cells may not provide an optimal source of myogenic cells
by
Macve, Joanne C., author.
Format:
Excerpt:
upon transplantation into immunocompetent, syngeneic recipients. However, prior irradiation of the
by
Cantos Pallarés, Miriam, author.
Format:
Excerpt:
International Consensus Conference on Liver Transplantation for HCC 2010;2:53-64. 6. Lencioni R, Di Bisceglie AM

Select an Action





